NCT05370521 2025-10-09
A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens
Spruce Biosciences
Phase 2 Terminated
Clinical Trials
12 trialsNCT02500147 2025-07-02
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
Columbia University
Phase 4 Terminated
NCT00203996 2023-03-21
Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
University of Chicago
Phase 4 Terminated
NCT01482286 2022-03-15
PULSE
Pennington Biomedical Research Center
Phase 3 Terminated
NCT02865915 2021-02-01
MLE4901 vs. Placebo for the Treatment of PCOS
Millendo Therapeutics, Inc.
Phase 2 Terminated
NCT01428245 2020-12-30
JCM026
University of Virginia
Phase NA Terminated
NCT01718444 2020-09-29
Progestin-induced Endometrial Shedding in PCOS (The PIES in PCOS Study)
University of Illinois at Chicago
Phase NA Terminated
NCT01607320 2018-09-20
PCOS
Prisma Health-Upstate
Phase NA Terminated
NCT01428193 2018-06-04
Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
University of Virginia
Phase NA Terminated
NCT00868140 2016-06-10
PCOS
Virginia Commonwealth University
Phase NA Terminated
NCT00729560 2014-09-08
PCOS
Virginia Commonwealth University
Phase NA Terminated
NCT00682890 2014-08-20
Combination Metformin and Oral Contraception for Polycystic Ovary Syndrome (PCOS)
Virginia Commonwealth University
Phase 4 Terminated